✦ LIBER ✦

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

✍ Scribed by Cavo, M; Bandini, G; Benni, M; Gozzetti, A; Ronconi, S; Rosti, G; Zamagni, E; Lemoli, R M; Bonini, A; Belardinelli, A

Book ID: 110010595
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 55 KB
Volume: 22
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701280

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose cyclophosphamide, BCNU, and VP

High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

✍ Axel R. Zander; Steven Culbert; Sundar Jagannath; Gary Spitzer; Michael Keating; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

Intermediate-dose busulfan and cyclophos

Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation

✍ Maschan, A A; Kryzanovskii, O I; Yourlova, M I; Skorobogatova, E V; Pashanov, E 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 37 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Allogeneic bone marrow transplantation f

Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)

✍ Deconinck, E; Cahn, J-Y; Milpied, N; Jouet, J-P; Vernant, J-P; Esperou, H; Liour 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Comparison of 100-day mortality rates as

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects

✍ Thall, P F; Champlin, R E; Andersson, B S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 212 KB